IL106307A - Isoxazole derivatives for the treatment of irritable bowel syndrome - Google Patents

Isoxazole derivatives for the treatment of irritable bowel syndrome

Info

Publication number
IL106307A
IL106307A IL106307A IL10630793A IL106307A IL 106307 A IL106307 A IL 106307A IL 106307 A IL106307 A IL 106307A IL 10630793 A IL10630793 A IL 10630793A IL 106307 A IL106307 A IL 106307A
Authority
IL
Israel
Prior art keywords
bowel syndrome
irritable bowel
treatment
alkyl
isoxazole derivatives
Prior art date
Application number
IL106307A
Other languages
English (en)
Other versions
IL106307A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL106307A0 publication Critical patent/IL106307A0/xx
Publication of IL106307A publication Critical patent/IL106307A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL106307A 1992-07-17 1993-07-12 Isoxazole derivatives for the treatment of irritable bowel syndrome IL106307A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91628192A 1992-07-17 1992-07-17

Publications (2)

Publication Number Publication Date
IL106307A0 IL106307A0 (en) 1993-11-15
IL106307A true IL106307A (en) 1997-06-10

Family

ID=25436992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106307A IL106307A (en) 1992-07-17 1993-07-12 Isoxazole derivatives for the treatment of irritable bowel syndrome

Country Status (23)

Country Link
US (1) US5434174A (es)
EP (1) EP0579507B1 (es)
JP (1) JPH06166620A (es)
CN (1) CN1049336C (es)
AT (1) ATE206918T1 (es)
AU (1) AU666377B2 (es)
CA (1) CA2100399A1 (es)
CZ (1) CZ284881B6 (es)
DE (1) DE69330926T2 (es)
DK (1) DK0579507T3 (es)
ES (1) ES2162808T3 (es)
HK (1) HK1013795A1 (es)
HU (1) HUT68727A (es)
IL (1) IL106307A (es)
MX (1) MX9304205A (es)
NO (1) NO304054B1 (es)
PH (1) PH30148A (es)
PL (1) PL172494B1 (es)
PT (1) PT579507E (es)
RU (1) RU2127111C1 (es)
TW (1) TW232653B (es)
UA (1) UA27720C2 (es)
ZA (1) ZA934969B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5962488A (en) * 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
US6362371B1 (en) * 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
FR2792529B1 (fr) * 1999-04-26 2001-09-28 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
UA76130C2 (en) * 2000-11-20 2006-07-17 Merck Patent Gmbh Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
EP1558081A4 (en) * 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc METHOD OF TREATING FUNCTIONAL INTESTINAL DISORDERS
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301798D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use IV
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US7684402B2 (en) 2006-05-15 2010-03-23 Faraday Technology Corp. Method and network device for fast look-up in a connection-oriented communication
WO2014105655A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK203089A (da) * 1988-04-28 1989-10-29 Beecham Group Plc Metaboliter
ATE172712T1 (de) * 1989-05-31 1998-11-15 Upjohn Co Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate
SE8904361D0 (sv) * 1989-12-22 1989-12-22 Astra Ab New chroman and thiochroman derivatives
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5158956A (en) * 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
EP0498590B1 (en) * 1991-02-08 1997-04-09 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes

Also Published As

Publication number Publication date
ATE206918T1 (de) 2001-11-15
ZA934969B (en) 1995-01-09
AU666377B2 (en) 1996-02-08
MX9304205A (es) 1995-01-31
NO932547D0 (no) 1993-07-13
PT579507E (pt) 2002-02-28
NO932547L (no) 1994-01-18
IL106307A0 (en) 1993-11-15
PL172494B1 (pl) 1997-09-30
UA27720C2 (uk) 2000-10-16
HU9302035D0 (en) 1993-10-28
DE69330926D1 (de) 2001-11-22
TW232653B (es) 1994-10-21
CN1111986A (zh) 1995-11-22
HK1013795A1 (en) 1999-09-10
CA2100399A1 (en) 1994-01-18
RU2127111C1 (ru) 1999-03-10
JPH06166620A (ja) 1994-06-14
DE69330926T2 (de) 2002-04-11
ES2162808T3 (es) 2002-01-16
DK0579507T3 (da) 2001-11-12
CZ137193A3 (en) 1994-11-16
PL299690A1 (en) 1994-03-21
EP0579507B1 (en) 2001-10-17
AU4199393A (en) 1994-01-20
US5434174A (en) 1995-07-18
PH30148A (en) 1997-01-21
CZ284881B6 (cs) 1999-03-17
NO304054B1 (no) 1998-10-19
EP0579507A1 (en) 1994-01-19
HUT68727A (en) 1995-07-28
CN1049336C (zh) 2000-02-16

Similar Documents

Publication Publication Date Title
IL106307A (en) Isoxazole derivatives for the treatment of irritable bowel syndrome
NZ315469A (en) Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
HUT64327A (en) Process for production azolic compounds and pharmaceutical preparations containing these compounds
NZ330118A (en) Thiophenopyrimidines, pharmaceutical compositions thereof and use in treating endocrine, psychiatric and neurologic conditions
MY111814A (en) Watersoluble azole antifungals
AU637695B2 (en) Therapeutic agents
ZA881726B (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6-carbozamides
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
MY111702A (en) 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
PT85035A (en) Process for preparing antiallergy and antiinflammatory agents of benzoxazolones of analogs
ES8401067A1 (es) Procedimiento analogo para preparar un derivado de tropil benzoato.
GB9125970D0 (en) New compounds
NO934741L (no) Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade
GB2132189B (en) Tropyl and pseudotropyl benzoates and their use in migraine treatment
TW275629B (es)
DE3271277D1 (en) Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
IL106862A (en) 5-phenyl 3-phenylprop-2-YL oxazolidones process for their preparation and pharmaceutical compositions containing them
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
TW360651B (en) Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics and intermediates for their preparation
HK58389A (en) Semicarbazides,their preparation and use
JO1621B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees